Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2621]

WCLC 2020: Two ADAURA analyses support use of osimertinib for patients with surgically resected, stage IB to IIIA non-small cell lung cancer

WCLC 2020: Two ADAURA analyses support use of osimertinib for patients with surgically resected, stage IB to IIIA...

WCLC 2020: Host immune classifier HIC assays may predict treatment response

WCLC 2020: Host immune classifier HIC assays may predict treatment response

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlatinib vs crizotinib in ALK positive NSCLC

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlatinib vs...

Singles or pairs in cancer cells

Singles or pairs in cancer cells

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlatinib versus in ALK NSCLC

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlatinib versus in...

WCLC 2020: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

WCLC 2020: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

WCLC 2020: Nivolumab effective treatment for malignant mesothelioma

WCLC 2020: Nivolumab effective treatment for malignant mesothelioma

WCLC 2020: TALENT study supports NLCST and NELSON trial results

WCLC 2020: TALENT study supports NLCST and NELSON trial results

WLCL 2020: Disparities highlighted among key groups

WLCL 2020: Disparities highlighted among key groups

WCLC 2020: Study shows safety of adaptive RT in NSCLC patients

WCLC 2020: Study shows safety of adaptive RT in NSCLC patients

More from ecancer